![](https://www.medicaldevice-network.com/wp-content/uploads/sites/23/2024/07/shutterstock_2119360763.jpg)
Vivani to start in-human trial for GLP-1 implant for treating obesity
Vivani Medical has announced plans to start the first clinical study of its investigational six-month glucagon-like peptide 1 (GLP-1) implant (exenatide implant) for chronic weight management in Q4 this year. The company plans to trial the implant in obese …